Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 1,088 shares of the business’s stock in a transaction on Monday, August 14th. The stock was sold at an average price of $97.91, for a total value of $106,526.08. Following the transaction, the executive vice president now directly owns 26,600 shares of the company’s stock, valued at $2,604,406. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Shares of Varian Medical Systems, Inc. (VAR) traded up 0.83% during mid-day trading on Tuesday, reaching $99.22. The company’s stock had a trading volume of 588,047 shares. The firm has a market capitalization of $9.11 billion, a PE ratio of 32.66 and a beta of 0.61. The firm has a 50-day moving average of $101.37 and a 200-day moving average of $93.90. Varian Medical Systems, Inc. has a 52 week low of $75.20 and a 52 week high of $107.08.

Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.09. The company had revenue of $662.40 million during the quarter, compared to the consensus estimate of $663.86 million. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The company’s revenue was up 3.0% on a year-over-year basis. During the same period last year, the firm earned $1.00 earnings per share. Equities research analysts forecast that Varian Medical Systems, Inc. will post $3.93 earnings per share for the current fiscal year.

WARNING: “Kolleen T. Kennedy Sells 1,088 Shares of Varian Medical Systems, Inc. (VAR) Stock” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/08/15/kolleen-t-kennedy-sells-1088-shares-of-varian-medical-systems-inc-var-stock.html.

VAR has been the subject of several analyst reports. BidaskClub cut Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Off Wall Street initiated coverage on Varian Medical Systems in a research note on Monday, April 24th. They set a “sell” rating for the company. Zacks Investment Research cut Varian Medical Systems from a “hold” rating to a “sell” rating in a research note on Friday, April 28th. Citigroup Inc. raised Varian Medical Systems from a “neutral” rating to a “buy” rating in a research note on Monday, May 15th. Finally, Jefferies Group LLC reissued a “buy” rating on shares of Varian Medical Systems in a research note on Thursday, May 11th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company’s stock. Varian Medical Systems presently has an average rating of “Hold” and a consensus target price of $96.28.

Several hedge funds have recently made changes to their positions in the stock. Manchester Capital Management LLC increased its stake in shares of Varian Medical Systems by 16.5% in the second quarter. Manchester Capital Management LLC now owns 1,057 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 150 shares in the last quarter. First Mercantile Trust Co. increased its stake in shares of Varian Medical Systems by 2.3% in the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock valued at $100,000 after buying an additional 25 shares in the last quarter. Parallel Advisors LLC increased its stake in shares of Varian Medical Systems by 16.7% in the first quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock valued at $113,000 after buying an additional 176 shares in the last quarter. Heritage Trust Co acquired a new stake in shares of Varian Medical Systems during the first quarter valued at $118,000. Finally, Penserra Capital Management LLC increased its stake in shares of Varian Medical Systems by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,610 shares of the medical equipment provider’s stock valued at $146,000 after buying an additional 140 shares in the last quarter. Institutional investors own 98.95% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.